Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





o-METHYLCYCLOHEXANONE								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 583-60-8; **Chemical Formula:** CH3C5H9CO
OSHA’s former limit for o-methylcyclohexanone was 100 ppm as an 8-hour TWA, with a skin notation. The Agency proposed revising this limit to 50 ppm as a TWA and 75 ppm as a STEL, and to retain the skin notation; NIOSH (Ex. 8-47, Table N1) concurred with this proposal. These limits are established in the final rule and are consistent with the limits recommended by the ACGIH. ortho-Methylcyclohexanone is a somewhat viscous liquid with an acetone-like odor.
o-Methylcyclohexanone has both irritative and narcotic effects at relatively low concentrations. The commercial product contains a mixture of isomers; however, toxicity data describe the effects of the ortho isomer only. Gross (as cited in Lehman and Flury 1943a/Ex. 1-962) reported that 450 ppm had irritative effects on the eyes and respiratory systems of rabbits, and 2500 ppm produced narcotic effects (Gross, as cited in Lehman and Flury 1943a/Ex. 1-962). Treon et al. (1943a/Ex. 1-393) reported the oral LD(50) to be between 1 and 1.25 g/kg for rabbits. Eye problems were observed at about 500 ppm, but exposure to 182 ppm produced no adverse effects (Treon, Crutchfield, and Kitzmiller 1943a/Ex. 1-393).
Rowe and Wolf (1963, as cited in ACGIH 1986/Ex. 1-3, p. 386) reported that concentrations of 100 ppm had no narcotic effects in humans but could cause irritation. No comments, other than NIOSH’s, were received on OSHA’s proposal to revise the limit for this substance.
Because a level of 100 ppm may represent an effect level for irritation in humans (Rowe and Wolf 1963, as cited in ACGIH 1986/Ex. 1-3, p. 386), OSHA finds that a reduction in its 100-ppm PEL is warranted. The Agency considers the irritation caused by exposure to this substance to be a material impairment of health. Therefore, OSHA is revising its limit for o-methylcyclohexanone to 50 ppm as an 8-hour TWA and 75 ppm as a 15-minute STEL. OSHA is also retaining its skin notation for this substance.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue